MedPath

Study of blood letting using leech application in the patients suffering from keloid.

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2020/03/023674
Lead Sponsor
Dr Pankaj Dixit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed patients of keloids irrespective of age, sex size, and site.

Patients willing to participate and have given a writen consent for the same

Exclusion Criteria

Uncontrolled D.M.

ï?? Seropositive patients- HIV, HbsAg

ï?? Patients having deranged coagulation profile

ï?? Patients taking antiplatelet drugs

ï?? Infection of or near the keloid.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in keloid using DLQI and POSAS scaleTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
arresting the local spread of keloidTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath